Click Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Click Therapeutics's estimated annual revenue is currently $41.7M per year.
- Click Therapeutics received $17.0M in venture funding in July 2018.
- Click Therapeutics's estimated revenue per employee is $193,750
- Click Therapeutics's total funding is $79M.
Employee Data
- Click Therapeutics has 215 Employees.
- Click Therapeutics grew their employee count by 17% last year.
Click Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder & CEO | Reveal Email/Phone |
2 | VP, Clinical Operations | Reveal Email/Phone |
3 | SVP, People | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | Associate Director, Clinical Innovation | Reveal Email/Phone |
6 | Director, Regulatory & Quality | Reveal Email/Phone |
7 | Associate Design Director | Reveal Email/Phone |
8 | Director | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Director, Clinical Operations | Reveal Email/Phone |
Click Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Click Therapeutics?
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click's industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click's lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
keywords:Biotechnology,Healthcare,Pharmaceuticals
$79M
Total Funding
215
Number of Employees
$41.7M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Click Therapeutics News
AI-backed remote monitoring and digital therapeutics company Biofourmis raised a ... Happify Health, Big Health and Click Therapeutics.
(Click), a leader in Digital Therapeutics as prescription medical treatments, today announced that it has secured a $15 million term loan...
(Click), a leader in Digital Therapeutics as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer,...
Click Therapeutics has raised a $52 million Series B co-led by Accelmed and HIG BioHealth Partners. The New York-based company develops digital prescription medical treatments for patients with chronic pain, autoimmune disorders and other health conditions. Additional Investors Health Catalyst ...
Less than a year after its last financing, Click Therapeutics raised $52 million to develop its portfolio of software-based treatments. The New York-based startup recently raised a series B round led by H.I.G. BioHealth Partners and Accelmed Partners II. Sanofi, an early investor in the company, ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $59.1M | 215 | 8% | N/A |
#2 | $15M | 215 | 4% | N/A |
#3 | $59.1M | 215 | 9% | N/A |
#4 | $7.5M | 215 | 8% | N/A |
#5 | $60.7M | 215 | 0% | N/A |
Click Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2016-04-22 | $0.8M | Undisclosed | Article | |
| 2018-07-24 | $17.0M | Undisclosed | Sanofi Ventures | Article |